Gene-based vaccines: Recent developments
- PMID: 20140820
Gene-based vaccines: Recent developments
Abstract
Gene-based vaccines are under development for a broad variety of applications, ranging from vaccines to immunotherapies for infectious diseases, cancer, autoimmune diseases and allergy. In addition, following the licensing of DNA vaccines for use in fish and horses, and DNA immunotherapy for the treatment of cancer in dogs, several veterinary uses of vaccines have been demonstrated for species ranging from fish and shrimp to cattle and horses. A variety of publications describing preclinical and clinical studies of the technologies used to increase the potency of gene-based vaccines, and research further elucidating the immune mechanisms involved have recently become available. This review discusses the progress and observations described in the recent literature, including a survey of the diseases and approaches that are being targeted with gene-based vaccines.
Similar articles
-
Gene-based vaccines: recent technical and clinical advances.Trends Mol Med. 2006 May;12(5):216-22. doi: 10.1016/j.molmed.2006.03.007. Epub 2006 Apr 18. Trends Mol Med. 2006. PMID: 16621717 Review.
-
Human clinical trials of plasmid DNA vaccines.Adv Genet. 2005;55:25-40. doi: 10.1016/S0065-2660(05)55002-8. Adv Genet. 2005. PMID: 16291211 Review.
-
Fish vaccine antigens produced or delivered by recombinant DNA technologies.Dev Biol Stand. 1997;90:267-77. Dev Biol Stand. 1997. PMID: 9270855 Review.
-
Hsp-based tumor vaccines: state-of-the-art and future directions.Curr Opin Mol Ther. 2007 Aug;9(4):385-91. Curr Opin Mol Ther. 2007. PMID: 17694451 Review.
-
Development of anthrax DNA vaccines.Curr Opin Mol Ther. 2004 Oct;6(5):506-12. Curr Opin Mol Ther. 2004. PMID: 15537052 Review.
Cited by
-
DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.PLoS One. 2013;8(2):e55571. doi: 10.1371/journal.pone.0055571. Epub 2013 Feb 14. PLoS One. 2013. PMID: 23457473 Free PMC article. Clinical Trial.
-
A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells.Cancer Immunol Immunother. 2011 Jul;60(7):1019-27. doi: 10.1007/s00262-011-1016-4. Epub 2011 Apr 17. Cancer Immunol Immunother. 2011. PMID: 21499904 Free PMC article.
-
Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy.Viruses. 2021 Feb 23;13(2):355. doi: 10.3390/v13020355. Viruses. 2021. PMID: 33672349 Free PMC article.
-
Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+ T cell immunity.J Transl Med. 2010 Dec 14;8:132. doi: 10.1186/1479-5876-8-132. J Transl Med. 2010. PMID: 21144062 Free PMC article.
-
Construction and In vitro Expression Analyses of a DNA Plasmid Encoding Dense Granule GRA5 Antigen of Toxoplasma gondii.Avicenna J Med Biotechnol. 2011 Jul;3(3):135-41. Avicenna J Med Biotechnol. 2011. PMID: 23407179 Free PMC article.